An international team of scientists, including those at the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, has devised a tool that could help design more successful clinical trials for new ...
Dec 20, 2021
0
22
Northwestern Medicine scientists have discovered a new biomarker to identify which patients with brain tumors called glioblastomas—the most common and malignant of primary brain tumors—might benefit from immunotherapy.
Nov 29, 2021
0
73
New Cleveland Clinic research has found that drugs originally designed to help treat Alzheimer's disease may hold promise for glioblastoma, the most common and lethal type of primary brain tumor. The findings were published ...
Nov 23, 2021
0
60
Scientists have discovered a new link that could bring the scientific and medical community closer to understanding why glioblastoma, the most common malignant brain tumor, is deadlier in males than females.
Oct 18, 2021
0
20
Glioblastoma multiformes is a potentially devastating brain tumor. Now, a collaboration between UConn Health and The Jackson Laboratory (JAX) is discovering what makes them so adaptable and dangerous and sometimes able to ...
Oct 7, 2021
0
38
Glioblastoma is the most lethal and malignant adult brain cancer that may arise from neuroglial stem or progenitor cells. Certain gene mutations or those with a known history of other cancers and radiation therapy may predispose ...
Sep 15, 2021
0
62
Neoadjuvant immune checkpoint blockade (ICB) is a promising treatment for melanoma and other cancer types, and has recently been shown to provide a modest survival benefit for patients with recurrent glioblastoma. To improve ...
Jun 29, 2021
0
13
For the first time, scientists from the German Cancer Consortium (DKTK) partner site in Essen/Düsseldorf have discovered stem cells of the hematopoietic system in glioblastomas, the most aggressive form of brain tumor. These ...
Jun 28, 2021
0
6
Researchers in a Horizon 2020 project called EDEN2020 have proven what they set out to do over 5 years ago: directionality of needle insertion plays a crucial role when infusing drugs into the brain.
Jun 22, 2021
0
11
The maker of the expensive brain cancer drug Gleostine has removed it from the Medicare drug rebate program, a move that could have dire consequences for some patients.
Jun 21, 2021
0
2
